AsiaIPEX is a one-stop-shop for players in the IP industry, facilitating IP trade and connection to the IP world. Whether you are a patent owner interested in selling your IP, or a manufacturer looking to buy technologies to upgrade your operation, you will find the portal a useful resource.

Back to search results

A-24 Enzymatic Assay of D-serine

Technology Benefits

ΓùÅπÇÇSimple: No complicated pre-treatment is neededΓùÅπÇÇPrecise: Almost free from L-amino acid noise ΓùÅπÇÇEasy: No high proficiency required to analyze the dataΓùÅπÇÇEfficient: Large quantity of sample can be processed in bulkΓùÅπÇÇSafe: Disposable; no infection riskΓùÅπÇÇCheap: Expensive instruments used in High-performance liquid chromatography (HPLC), capillary electrophoresis, or gas chromatography are not needed

Technology Application

D-Serine Assay, Diagnostic Kit for Schizophrenia and AlzheimerΓÇÖs Disease

Detailed Technology Description

None

Supplementary Information

Inventor: YOSHIMURA, Tohru | ITO, Tomokazu
Priority Number: WO2008047802A1
IPC Current: C12N001500 | C12N000115 | C12N000119 | C12N000121 | C12N000510 | C12N000988 | C12N001509 | C12Q0001527
Assignee Applicant: National University Corporation Nagoya University
Title: D-SERINE DEHYDRATASE AND USE THEREOF | D-SÉRINE DÉSHYDRATASE ET SON UTILISATION
Usefulness: D-SERINE DEHYDRATASE AND USE THEREOF | D-SÉRINE DÉSHYDRATASE ET SON UTILISATION
Summary: The protein having D-serine dehydratase activity is useful as reagent for quantifying D-serine (all claimed), for diagnosing schizophrenia, Alzheimer's disease or bovine spongiform encephalopathy (BSE).
Novelty: Novel protein having D-serine dehydratase activity, useful as reagent for quantifying D-serine for diagnosing schizophrenia, Alzheimer's disease or bovine spongiform encephalopathy

Industry

Biomedical

Sub Group

DNA/Gene Engineering

Country/Region

USA

For more information, please click Here